TINAVI MEDICAL TECHNOLOGIES CO.,LTD. Tinavi Medical Technologies Co.,Ltd. Share Price
Equities
688277
CNE100004256
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.72 CNY | +4.18% |
|
+12.37% | -33.84% |
| Sales 2022 | 156M 21.56M 1.8B | Sales 2023 | 210M 28.99M 2.42B | Capitalization | 5.92B 817M 68.16B |
|---|---|---|---|---|---|
| Net income 2022 | -111M -15.32M -1.28B | Net income 2023 | -156M -21.53M -1.8B | EV / Sales 2022 | 31 x |
| Net cash position 2022 | 153M 21.14M 1.76B | Net cash position 2023 | 141M 19.46M 1.62B | EV / Sales 2023 | 27.5 x |
| P/E ratio 2022 |
-45.7
x | P/E ratio 2023 |
-37.7
x | Employees | 362 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.18% | ||
| 1 week | +12.37% | ||
| Current month | -7.23% | ||
| 1 month | -8.40% | ||
| 3 months | -20.51% | ||
| 6 months | -34.19% | ||
| Current year | -33.84% |
1 week
7.66
8.73
1 month
7.669.65
Current year
7.5013.46
1 year
7.5019.78
3 years
7.5044.76
5 years
7.50141.60
10 years
7.50141.60
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Xu
CEO | Chief Executive Officer | 50 | 01/14/01 |
Song Gen Zhang
FOU | Founder | 58 | 22/10/22 |
Min Qi
DFI | Director of Finance/CFO | 42 | 01/12/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yang Xu
BRD | Director/Board Member | 57 | 07/23/07 |
Rui Jun Zhang
BRD | Director/Board Member | 62 | 07/23/07 |
Song Gen Zhang
FOU | Founder | 58 | 22/10/22 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 8.72 | +4.18% | 3,970,819 |
| 25/24/25 | 8.37 | +1.58% | 3,298,645 |
| 24/24/24 | 8.24 | +1.48% | 2,191,383 |
| 23/24/23 | 8.12 | +1.88% | 2,739,547 |
| 22/24/22 | 7.97 | +2.71% | 3,729,251 |
End-of-day quote Shanghai S.E., April 26, 2024
More quotes
Tinavi Medical Technologies Co Ltd is a China-based company mainly engaged in the research, development, production, sales and service of orthopedic surgery navigation and positioning robots. The Company's products and services for medical institutions mainly include orthopedic surgery navigation and positioning robots, GD-A, GD-2000/GD-S and TiRobot, surgery center professional engineering, supporting equipment and consumables and technology services. The Company mainly conducts its businesses within the domestic market.
Calendar
22/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -33.84% | 541M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- 688277 Stock
